GCM
PRAH

Glenview Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Glenview Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-93,925
Closed -$11.8M – 76
2020
Q4 		$11.8M Hold
93,925
– – 0.27% 48
2020
Q3 		$9.53M Buy
93,925
+71,346
+316% +$7.27M 0.3% 40
2020
Q2 		$2.2M Buy
+22,579
New +$2.1M 0.06% 43
2020
Q1 		– Sell
-252,983
Closed -$28.1M – 57
2019
Q4 		$28.1M Buy
+252,983
New +$26M 0.25% 44

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Glenview Capital Management's PRAH Position: Q1 2021 in Review

Glenview Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 93,925 shares — an estimated $11.8M sold.

Glenview Capital Management first reported a position in PRAH in Q4 2019 and held it in 4 quarters. The position peaked at $28.1M in Q4 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Glenview Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Glenview Capital Management sold 93,925 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $11.8M.
  • Glenview Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 4 quarters.
  • Glenview Capital Management's PRA Health Sciences, Inc. position peaked at $28.1M in Q4 2019.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Glenview Capital Management's 13F filing for Q1 2021, filed 17 May 2021.